When to order a biopsy to characterise a metastatic relapse in breast cancer

Biopsy of liver metastasis for women with breast cancer: Impact on survival

(2012) Edoardo Botteri et al.   BREAST

Abstract 273: Protein kinase C-iota self regulates its expression by regulating the activity of the transcription factor Elk-1

(2012) Prajit Pillai P. Pillai et al.   CANCER RESEARCH

Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression

(2012) Linda Sofie Lindström et al.   JOURNAL OF CLINICAL ONCOLOGY

Should liver metastases of breast cancer be biopsied to improve treatment choice?

(2011) G. Curigliano et al.   ANNALS OF ONCOLOGY

Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies

(2011) Eitan Amir et al.   CANCER TREATMENT REVIEWS

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

(2011) Naoki Niikura et al.   JOURNAL OF CLINICAL ONCOLOGY

Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer

(2011) Eitan Amir et al.   JOURNAL OF CLINICAL ONCOLOGY

HER2 status in a population-derived breast cancer cohort: discordances during tumor progression

(2010) Ulla Wilking et al.   BREAST CANCER RESEARCH AND TREATMENT

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

(2010) M. Elizabeth H. Hammond et al.   JOURNAL OF CLINICAL ONCOLOGY

Genome remodelling in a basal-like breast cancer metastasis and xenograft

(2010) Li Ding et al.   NATURE

Triple-Negative Breast Cancer

(2010) William D. Foulkes et al.   NEW ENGLAND JOURNAL OF MEDICINE

A diagnostic paradigm for resectable liver lesions: to biopsy or not to biopsy?

(2010) Adrian B. Cresswell et al.   HPB

Third consensus on medical treatment of metastatic breast cancer

(2009) S. Beslija et al.   ANNALS OF ONCOLOGY

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

(2009) C. Liedtke et al.   ANNALS OF ONCOLOGY

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

(2009) C. Simmons et al.   ANNALS OF ONCOLOGY

Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Central Nervous System Metastases

(2009) Brian Leyland-Jones   JOURNAL OF CLINICAL ONCOLOGY

HER-2/neu expression in primary and metastatic breast cancer

(2008) Elyse E. Lower et al.   BREAST CANCER RESEARCH AND TREATMENT

Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases

(2008) J. M. Wu et al.   CLINICAL CANCER RESEARCH

Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol

(2008) L. M. Peterson et al.   JOURNAL OF NUCLEAR MEDICINE

Comparison of HER-2 and Hormone Receptor Expression in Primary Breast Cancers and Asynchronous Paired Metastases: Impact on Patient Management

(2008) V. Guarneri et al.   ONCOLOGIST